Showing results 11 to 28 of 28
< previous
| Issue Date | Title | Author(s) |
| 2023-02-15 | Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. | Li, Y; McGowan, E; Chen, S; Santos, J; Yin, H; Lin, Y |
| 2019-07-02 | Low level of CENP‐E promotes growth of hepatocellular carcinoma and is associated with adverse clinical features | Lin, Y; He, P; Hu, P; Chen, H; Chen, Y; McGowan, E |
| 2019-07-01 | Low level of centromere-associated protein E promotes growth of hepatocellular carcinoma and is associated with adverse clinical features | Lin, Y; He, P; Hu, P; Chen, H; Chen, Y; McGowan, E |
| 2022 | Metformin Alleviates Endometriosis and Potentiates Endometrial Receptivity via Decreasing VEGF and MMP9 and Increasing Leukemia Inhibitor Factor and HOXA10. | Cheng, J; Li, C; Ying, Y; Lv, J; Qu, X; McGowan, E; Lin, Y; Zhu, X |
| 2019-07 | A novel anti-tumorigenic mechanism by herbal extract saikosaponin-d through p-STAT3/C/EBPβ signaling suppression of COX-2 in liver cancer. | Lin, Y; He, S; Li, Y; Chen, H; Zhu, X; McGowan, E |
| 2021-07-01 | P-86 The importance of sphingosine kinase 1 isoform expression in the gut-liver axis | Chen, H; Lin, Y; Chen, Y; Chen, S; Nassif, N; McGowan, E |
| 2020-01-01 | PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges | McGowan, E; Lin, Q; Ma, G; Yin, H; Chen, S; Lin, Y |
| 2019-12-06 | Phase 1 clinical trial of PD-1 knockout anti-MUC1 CAR-T cells in the treatment of patients with non-small cell lung cancer | Lin, Y; Chen, S; Shupeng, Z; An, H; Yin, H; McGowan, E |
| 2019-01-01 | Saikosaponin-D suppresses COX2 through p-STAT3/C/EBPβ signaling pathway in liver cancer: A novel mechanism of action | Ren, M; McGowan, E; Li, Y; Zhu, X; Lu, X; Zhu, Z; Lin, Y; He, S |
| 2021-06-30 | Seaweed Laminaria japonica peptides possess strong anti-liver cancer effects | Chen, H; Wu, Y; Chen, Y; Li, Y; McGowan, E; Lin, Y |
| 2019-07-02 | Serglycin level in peripheral circulating blood cells has prognostic significance in patients with hepatocellular carcinoma | Chen, H; Li, Y; Lu, H; McGowan, E; Lin, Y |
| 2019-07-01 | Serglycin level in peripheral circulating blood cells has prognostic significance in patients with hepatocellular carcinoma | Chen, H; Li, Y; Chen, Y; McGowan, E; Lin, Y |
| 2023-03 | Sex steroid hormones and DNA repair regulation: Implications on cancer treatment responses. | Rangsrikitphoti, P; Marquez-Garban, DC; Pietras, RJ; McGowan, E; Boonyaratanakornkit, V |
| 2020-01-08 | Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease. | Sukocheva, OA; Lukina, E; McGowan, E; Bishayee, A; Donev, R |
| 2015-11-25 | Sphingosine Kinase 1 (SK1-43kDa) isoform expression may contribute to cancer aggressiveness | Hatoum, D; Bok, CF; Touw, A; Nassif, N; McGowan, E |
| 2021-07-07 | Studying the Oncosuppressive Functions of PTENP1 as a ceRNA | Travis, G; Haddadi, N; Simpson, A; Marsh, D; McGowan, E; Nassif, N; Poliseno, L |
| 2021-06-30 | The anti-tumor effect of Curcuma phaeocaulis Cyclepeptide in human hepatoma HepG2 cells | Chen, H; Li, Y; Wu, Y; Li, Y; McGowan, E; Lin, Y |
| 2021-06-30 | The importance of Sphingosine kinase 1 isoform expression in the gut-liver axis | Chen, H; Lin, Y; Chen, Y; McGowan, E |
